• Home
  • Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.

Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.

Author List
Chang T, Krisman K, Theobald EH, Xu J, Akutagawa J, Lauchle JO, Kogan S, Braun BS, Shannon K
Publication
The Journal of clinical investigation
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1167255
Publication Year
2012
PubMed ID
23221337
Publication Title
Chang T, Krisman K, Theobald EH, Xu J, Akutagawa J, Lauchle JO, Kogan S, Braun BS, Shannon K. Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice. J Clin Invest. 2013 Jan; 123(1):335-9.